Thomas B Smith - Net Worth and Insider Trading

Thomas B Smith Net Worth

The estimated net worth of Thomas B Smith is at least $26,491 dollars as of 2023-03-22. Thomas B Smith is the Chief Medical Officer of BioDelivery Sciences International Inc and owns about 4,739 shares of BioDelivery Sciences International Inc (BDSI) stock worth over $26,491. Details can be seen in Thomas B Smith's Latest Holdings Summary section.

Transaction Summary of Thomas B Smith

To

Thomas B Smith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas B Smith owns 2 companies in total, including BioDelivery Sciences International Inc (BDSI) , and Collegium Pharmaceutical Inc (COLL) .

Click here to see the complete history of Thomas B Smith’s form 4 insider trades.

Insider Ownership Summary of Thomas B Smith

Ticker Comapny Transaction Date Type of Owner
BDSI BioDelivery Sciences International Inc 2020-01-31 Chief Medical Officer
COLL Collegium Pharmaceutical Inc 2022-03-23 EVP and Chief Medical Officer

Thomas B Smith Latest Holdings Summary

Thomas B Smith currently owns a total of 1 stock. Thomas B Smith owns 4,739 shares of BioDelivery Sciences International Inc (BDSI) as of January 31, 2020, with a value of $26,491.

Latest Holdings of Thomas B Smith

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BDSI BioDelivery Sciences International Inc 2020-01-31 4,739 5.59 26,491

Holding Weightings of Thomas B Smith


Thomas B Smith Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas B Smith has made a total of 1 transactions in BioDelivery Sciences International Inc (BDSI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in BioDelivery Sciences International Inc is the sale of 2,927 shares on January 31, 2020, which brought Thomas B Smith around $15,747.

Insider Trading History of Thomas B Smith

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
BDSI
BioDelivery Sciences International Inc
2020-01-31
Sell
2,927.00
-38.18%
$5.38
$15,747.30
4,739.00
$5.59
3.90%
-
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas B Smith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas B Smith Ownership Network

Ownership Network List of Thomas B Smith

No Data

Ownership Network Relation of Thomas B Smith


Thomas B Smith Owned Company Details

What does BioDelivery Sciences International Inc do?

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

Who are the key executives at BioDelivery Sciences International Inc?

Thomas B Smith is the Chief Medical Officer of BioDelivery Sciences International Inc. Other key executives at BioDelivery Sciences International Inc include director & Chief Executive Officer Jeffrey Allen Bailey , See Remarks James Vollins , and See Remarks Scott M. Plesha .

BioDelivery Sciences International Inc (BDSI) Insider Trades Summary

Over the past 18 months, Thomas B Smith made no insider transaction in BioDelivery Sciences International Inc (BDSI). Other recent insider transactions involving BioDelivery Sciences International Inc (BDSI) include a net purchase of 34,587 shares made by Mark A Sirgo , a net purchase of 357,800 shares made by Kevin Kotler , and a net purchase of 100,000 shares made by Broadfin Healthcare Master Fund Ltd .

In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc (BDSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 28,541 shares of BioDelivery Sciences International Inc (BDSI) were sold and 502,387 shares were bought by its insiders, resulting in a net purchase of 473,846 shares.

BioDelivery Sciences International Inc (BDSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NAS:BDSI Insider Transactions

20/Page
Total 0
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Thomas B Smith Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas B Smith. You might contact Thomas B Smith via mailing address: Biodelivery Sciences International, Inc., 4131 Parklake Ave Suite 225, Raleigh Nc 27612.